Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
BMC Gastroenterology|August 1, 2021
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year studyYuko Nagaoki, Hideyuki Hyogo, Yuwa Ando, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 27, 2016
Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis CKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.Hepatology Communications|March 13, 2019
Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver CirrhosisAkira Hiramatsu, Hiroshi Aikata, Shinsuke Uchikawa, et al.Clinical and Translational Gastroenterology|July 18, 2020
Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular CarcinomaMasami Yamauchi, Atsushi Ono, Akira Ishikawa, et al.Journal of Gastroenterology and Hepatology|November 20, 2015
Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort studyYuko Nagaoki, Hiroshi Aikata, Norihito Nakano, et al.Medicine|June 30, 2021
Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patientsEisuke Murakami, Takashi Nakahara, Akira Hiramatsu, et al.Journal of Gastroenterology|November 9, 2016
ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis CKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.Internal Medicine (Tokyo, Japan)|July 1, 2021
Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with SorafenibKenji Yamaoka, Tomokazu Kawaoka, Hiroshi Aikata, et al.Liver Cancer|May 12, 2021
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal VeinYumi Kosaka, Tomoki Kimura, Tomokazu Kawaoka, et al.Plos One|August 11, 2017
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapyYuko Nagaoki, Michio Imamura, Hiroshi Aikata, et al.Pageof 8